Zeke Capital Advisors, LLC Annovis Bio, Inc. Transaction History

Zeke Capital Advisors, LLC

  • $1.53 Billion
  • Q4 2022

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 09, 2020
SELL
$3.84 - $6.78 $105,960 - $187,087
-27,594 Closed
0 $0
Q1 2020

Apr 24, 2020
BUY
$2.66 - $9.59 $73,400 - $264,626
27,594 New
27,594 $83,000

Others Institutions Holding ANVS

# of Institutions
45
Shares Held
1.16M
Call Options Held
229K
Put Options Held
934K
View Full List

About Annovis Bio, Inc.

ANVS Quotes by TradingView
  • Ticker ANVS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,163,920
  • Market Cap $58M
  • Description
  • Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...
More about ANVS
Track This Portfolio

Track Zeke Capital Advisors, LLC Portfolio

Follow Zeke Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zeke Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zeke Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email